LRI Investments’s RxSight RXST Stock Holding History

LRI Investments’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-58	Closed	-$604	–	1492
2025 Q4	$604	Buy	+58	New	+$582	﹤0.01%	1294

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

LRI Investments's RXST Position: Q1 2026 in Review

LRI Investments sold out of RxSight (RXST) in Q1 2026, closing a stake of 58 shares — an estimated $604 sold.

LRI Investments first reported a position in RXST in Q4 2025 and held it in 1 quarter. The position peaked at $604 in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

LRI Investments reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
LRI Investments sold 58 RxSight shares in Q1 2026, an estimated $604.
LRI Investments first reported a position in RxSight in Q4 2025 and held it in 1 quarter.
LRI Investments's RxSight position peaked at $604 in Q4 2025.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on LRI Investments's 13F filing for Q1 2026, filed 30 Apr 2026.